MURRAY CHRISTINE sold 31.3% of their position (5K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market sale worth $6.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2023ACC: 0001567619-23-000069
Director
Since Jan 2019
-5K
Net shares
Net seller
$6.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$1.22
Trade value
$6.10K
% of position
31.3%
12/29/2022
16K→11K
Total
Net shares
−5K
Net value
-$6.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/29/2022 | S · Sale | −5K | $1.22 | $6.10K | 31.3% | 16K | 11K |
| Total | −5K | -$6.10K | ||||||
Derivative Transactions0
No derivative transactions reported